Exact Mass: 279.1601

Exact Mass Matches: 279.1601

Found 73 metabolites which its exact mass value is equals to given mass value 279.1601, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tiocarbazil

S-benzyl di-sec-butylthiocarbamate

C16H25NOS (279.1657)


   

Doxepin

dimethyl(3-{9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine

C19H21NO (279.1623)


Doxepin hydrochloride is a dibenzoxepin-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, doxepin does not affect mood or arousal, but may cause sedation. In depressed individuals, doxepin exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as doxepin and amitriptyline, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. Doxepin has less sedative and anticholinergic effects than amitriptyline. See toxicity section below for a complete listing of side effects. Doxepin may be used to treat depression and insomnia. Unlabeled indications include chronic and neuropathic pain, and anxiety. Doxepin may also be used as a second line agent to treat idiopathic urticaria. D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists EAWAG_UCHEM_ID 3676; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 3676

   

Oxamniquine

(7-nitro-2-{[(propan-2-yl)amino]methyl}-1,2,3,4-tetrahydroquinolin-6-yl)methanol

C14H21N3O3 (279.1583)


An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martidale, The Extra Pharmacopoeia, 31st ed, p121) P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

Tandex

tert-butyl N-[3-(dimethylcarbamoylamino)phenyl]carbamate

C14H21N3O3 (279.1583)


CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3869; ORIGINAL_PRECURSOR_SCAN_NO 3867 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3873; ORIGINAL_PRECURSOR_SCAN_NO 3871 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3840; ORIGINAL_PRECURSOR_SCAN_NO 3837 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3871; ORIGINAL_PRECURSOR_SCAN_NO 3866 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3852 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3856; ORIGINAL_PRECURSOR_SCAN_NO 3854 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7846; ORIGINAL_PRECURSOR_SCAN_NO 7844 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7884; ORIGINAL_PRECURSOR_SCAN_NO 7882 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7894; ORIGINAL_PRECURSOR_SCAN_NO 7893 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7921; ORIGINAL_PRECURSOR_SCAN_NO 7919 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7939; ORIGINAL_PRECURSOR_SCAN_NO 7937 CONFIDENCE standard compound; INTERNAL_ID 471; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7937; ORIGINAL_PRECURSOR_SCAN_NO 7936

   

Etamiphylline

7-[2-(diethylamino)ethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C13H21N5O2 (279.1695)


Etamiphylline belongs to the family of Xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

E-10-Hydroxynortriptyline

(2E)-2-[3-(methylamino)propylidene]tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

C19H21NO (279.1623)


E-10-Hydroxynortriptyline is only found in individuals that have used or taken Amitriptyline. E-10-Hydroxynortriptyline is a metabolite of Amitriptyline. E-10-hydroxynortriptyline belongs to the family of Dibenzocycloheptenes. These are compounds containing a dibenzocycloheptene moiety, which consists of two benzene connected by a cycloheptene ring.

   

10-Hydroxynortriptyline

2-[3-(methylamino)propylidene]tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

C19H21NO (279.1623)


   

4-P-Pdot

N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propanimidate

C19H21NO (279.1623)


   

4-(3-Tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one

4-(3-Tert-butylamino-2-hydroxypropoxy)benzimidazol-2-one hydrochloride, (+-)-isomer

C14H21N3O3 (279.1583)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

Tezampanel

6-(2-(1H-Tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid

C13H21N5O2 (279.1695)


   

Axinisothiocyanate M

Axinisothiocyanate M

C16H25NOS (279.1657)


   
   

Maybridge4_001256

Maybridge4_001256

C13H21N5S (279.1518)


   

2,4,6,12-Tetradecatetraene-8,10-diynoic acid piperidide|tetradeca-2t,4t,6t,12t-tetraene-8,10,-diynoic-piperidide

2,4,6,12-Tetradecatetraene-8,10-diynoic acid piperidide|tetradeca-2t,4t,6t,12t-tetraene-8,10,-diynoic-piperidide

C19H21NO (279.1623)


   

(2S,3S)-2-((1R,4S)-4-isothiocyanato-4-methylcyclohexyl)-2-methyl-3-((E)-3-methylbut-1-enyl)oxirane|7alpha,8alpha-epoxytheonellin isothiocyanate

(2S,3S)-2-((1R,4S)-4-isothiocyanato-4-methylcyclohexyl)-2-methyl-3-((E)-3-methylbut-1-enyl)oxirane|7alpha,8alpha-epoxytheonellin isothiocyanate

C16H25NOS (279.1657)


   

Clausenapin

Clausenapin

C19H21NO (279.1623)


   

(E,E)-2,4-Tetradecadiene-8,10,12-triynoic acid|tetradeca-2t,4t-diene-8,10,12-triynoic-piperidide

(E,E)-2,4-Tetradecadiene-8,10,12-triynoic acid|tetradeca-2t,4t-diene-8,10,12-triynoic-piperidide

C19H21NO (279.1623)


   

Semicarbazone---Jasmololone

Semicarbazone---Jasmololone

C14H21N3O3 (279.1583)


   

doxepin

Cidoxepin

C19H21NO (279.1623)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists CONFIDENCE standard compound; INTERNAL_ID 1532

   

oxamniquine

oxamniquine

C14H21N3O3 (279.1583)


P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent [Raw Data] CB143_Oxamniquine_pos_50eV_CB000053.txt [Raw Data] CB143_Oxamniquine_pos_40eV_CB000053.txt [Raw Data] CB143_Oxamniquine_pos_30eV_CB000053.txt [Raw Data] CB143_Oxamniquine_pos_20eV_CB000053.txt [Raw Data] CB143_Oxamniquine_pos_10eV_CB000053.txt

   

Etamiphylline

Etamiphylline

C13H21N5O2 (279.1695)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

10-Hydroxyprotriptyline

10-Hydroxyprotriptyline

C19H21NO (279.1623)


   

10-Hydroxynortryptyline

10-Hydroxynortryptyline

C19H21NO (279.1623)


   

Queryl

7-[2-(diethylamino)ethyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C13H21N5O2 (279.1695)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

4-Nitrobenzyl N,N-diisopropylcarbamimidate

4-Nitrobenzyl N,N-diisopropylcarbamimidate

C14H21N3O3 (279.1583)


   

1-benzyl-spiro[benzofuran-3,4-piperidine]

1-benzyl-spiro[benzofuran-3,4-piperidine]

C19H21NO (279.1623)


   

H-Hyp(tBu)-Otbu.HCl

H-Hyp(tBu)-Otbu.HCl

C13H26ClNO3 (279.1601)


   

tert-butyl 4-(5-hydroxypyridin-2-yl)piperazine-1-carboxylate

tert-butyl 4-(5-hydroxypyridin-2-yl)piperazine-1-carboxylate

C14H21N3O3 (279.1583)


   

1-(5-Methoxy-2-Methyl-4-nitrophenyl)-N,N-dimethylpiperidin-4-amine

1-(5-Methoxy-2-Methyl-4-nitrophenyl)-N,N-dimethylpiperidin-4-amine

C14H21N3O3 (279.1583)


   

3-(4-semicarbazido)propyltriethoxysilane

3-(4-semicarbazido)propyltriethoxysilane

C10H25N3O4Si (279.1614)


   

2-(2-Methoxyethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(2-Methoxyethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C14H22BNO4 (279.1642)


   

1-bromotetradecane-14,14,14-d3

1-bromotetradecane-14,14,14-d3

C14H26BrD3 (279.1641)


   

3-(6-chloropyridin-2-yl)-9-methyl-3,9-diazaspiro[5.5]undecane

3-(6-chloropyridin-2-yl)-9-methyl-3,9-diazaspiro[5.5]undecane

C15H22ClN3 (279.1502)


   

1-Benzyl-4-(4-methoxyphenyl)tetrahydropyridine

1-Benzyl-4-(4-methoxyphenyl)tetrahydropyridine

C19H21NO (279.1623)


   

1-Benzyl-4-(2-methoxyphenyl)tetrahydropyridine

1-Benzyl-4-(2-methoxyphenyl)tetrahydropyridine

C19H21NO (279.1623)


   

1-Boc-4-(Pyrimidin-2-yloxy)piperidine

1-Boc-4-(Pyrimidin-2-yloxy)piperidine

C14H21N3O3 (279.1583)


   

Isopropyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate

Isopropyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate

C14H22BNO4 (279.1642)


   

Tributylmethylammonium bromide

Tributylmethylammonium bromide

C13H30BrN (279.1561)


   

2-(2-(BENZYLOXY)-5-(TERT-BUTYL)PHENYL)ACETONITRILE

2-(2-(BENZYLOXY)-5-(TERT-BUTYL)PHENYL)ACETONITRILE

C19H21NO (279.1623)


   

butyl(tripropyl)azanium,bromide

butyl(tripropyl)azanium,bromide

C13H30BrN (279.1561)


   

1-BENZYL-3H-SPIRO[BENZOFURAN-2,4-PIPERIDINE]

1-BENZYL-3H-SPIRO[BENZOFURAN-2,4-PIPERIDINE]

C19H21NO (279.1623)


   
   

1-benzyl-4-(3-methoxyphenyl)-3,6-dihydro-2H-pyridine

1-benzyl-4-(3-methoxyphenyl)-3,6-dihydro-2H-pyridine

C19H21NO (279.1623)


   

5-(2-Methoxyethoxy)pyridine-3-boronic acid pinacol ester

5-(2-Methoxyethoxy)pyridine-3-boronic acid pinacol ester

C14H22BNO4 (279.1642)


   

L-Phenylalanine,N-[(1,1-dimethylethoxy)carbonyl]-, hydrazide

L-Phenylalanine,N-[(1,1-dimethylethoxy)carbonyl]-, hydrazide

C14H21N3O3 (279.1583)


   

Decyltrimethylammonium bromide

N,N,N-Trimethyldecan-1-aminium bromide

C13H30BrN (279.1561)


D013501 - Surface-Active Agents

   

Methylamino-PEG4-acid HCl

Methylamino-PEG4-acid HCl

C12H25NO6 (279.1682)


   

4-Methyl-3-(3-Morpholinopropoxy)phenylboronic acid

4-Methyl-3-(3-Morpholinopropoxy)phenylboronic acid

C14H22BNO4 (279.1642)


   

tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate

tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate

C13H21N5O2 (279.1695)


   
   

tert-butyl 4-(6-aminopyrimidin-4-yl)piperazine-1-carboxylate

tert-butyl 4-(6-aminopyrimidin-4-yl)piperazine-1-carboxylate

C13H21N5O2 (279.1695)


   

Tezampanel

LY 293558;LY293558;LY-293558

C13H21N5O2 (279.1695)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

10-Hydroxynortriptyline

10-Hydroxynortriptyline

C19H21NO (279.1623)


   

(R)-oxamniquine

(R)-oxamniquine

C14H21N3O3 (279.1583)


   

{(2s)-7-Nitro-2-[(Propan-2-Ylamino)methyl]-1,2,3,4-Tetrahydroquinolin-6-Yl}methanol

{(2s)-7-Nitro-2-[(Propan-2-Ylamino)methyl]-1,2,3,4-Tetrahydroquinolin-6-Yl}methanol

C14H21N3O3 (279.1583)


   

N(6)-(D-ribulosyl)-L-lysine

N(6)-(D-ribulosyl)-L-lysine

C11H23N2O6+ (279.1556)


   

S-(1,4-dihydroxynonan-3-yl)-L-cysteine

S-(1,4-dihydroxynonan-3-yl)-L-cysteine

C12H25NO4S (279.1504)


   

3-Acetyl-9-(3-methylbutyl)carbazole

3-Acetyl-9-(3-methylbutyl)carbazole

C19H21NO (279.1623)


   

N-Benzyl-trans-(3-acetyl-4-phenyl)pyrrolidine

N-Benzyl-trans-(3-acetyl-4-phenyl)pyrrolidine

C19H21NO (279.1623)


   

1-Methyl-3-para-methylbenzoyl-4-phenylpyrrolidine (3,4-trans)

1-Methyl-3-para-methylbenzoyl-4-phenylpyrrolidine (3,4-trans)

C19H21NO (279.1623)


   

N-Methyl-N-trimethylsilylcarbamic acid 2-sec-butylphenyl ester

N-Methyl-N-trimethylsilylcarbamic acid 2-sec-butylphenyl ester

C15H25NO2Si (279.1654)


   

tert-butyl N-[3-(dimethylcarbamoylamino)phenyl]carbamate

tert-butyl N-[3-(dimethylcarbamoylamino)phenyl]carbamate

C14H21N3O3 (279.1583)


   
   

(+/-)AMETHOPTERIN

4-(3-Tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one

C14H21N3O3 (279.1583)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

NA-Taurine 10:0

NA-Taurine 10:0

C12H25NO4S (279.1504)


   

8-isothiocyanato-4a,8-dimethyl-2-(prop-1-en-2-yl)-hexahydro-1h-naphthalen-2-ol

8-isothiocyanato-4a,8-dimethyl-2-(prop-1-en-2-yl)-hexahydro-1h-naphthalen-2-ol

C16H25NOS (279.1657)


   

1-(piperidin-1-yl)tetradeca-2,4,6,12-tetraen-8,10-diyn-1-one

1-(piperidin-1-yl)tetradeca-2,4,6,12-tetraen-8,10-diyn-1-one

C19H21NO (279.1623)


   

(2e,4e,6e,12e)-1-(piperidin-1-yl)tetradeca-2,4,6,12-tetraen-8,10-diyn-1-one

(2e,4e,6e,12e)-1-(piperidin-1-yl)tetradeca-2,4,6,12-tetraen-8,10-diyn-1-one

C19H21NO (279.1623)


   

1-(piperidin-1-yl)tetradeca-2,4-dien-8,10,12-triyn-1-one

1-(piperidin-1-yl)tetradeca-2,4-dien-8,10,12-triyn-1-one

C19H21NO (279.1623)


   

1-{3-acetyl-2-hydroxy-7-methyl-5h,6h,7h,7ah-pyrrolo[3,2-b]pyridin-4-yl}-4-aminobutan-1-one

1-{3-acetyl-2-hydroxy-7-methyl-5h,6h,7h,7ah-pyrrolo[3,2-b]pyridin-4-yl}-4-aminobutan-1-one

C14H21N3O3 (279.1583)


   

axinisothiocyanate j

axinisothiocyanate j

C16H25NOS (279.1657)


   

(2e,4e)-1-(piperidin-1-yl)tetradeca-2,4-dien-8,10,12-triyn-1-one

(2e,4e)-1-(piperidin-1-yl)tetradeca-2,4-dien-8,10,12-triyn-1-one

C19H21NO (279.1623)


   

1-[(7s,7ar)-3-acetyl-2-hydroxy-7-methyl-5h,6h,7h,7ah-pyrrolo[3,2-b]pyridin-4-yl]-4-aminobutan-1-one

1-[(7s,7ar)-3-acetyl-2-hydroxy-7-methyl-5h,6h,7h,7ah-pyrrolo[3,2-b]pyridin-4-yl]-4-aminobutan-1-one

C14H21N3O3 (279.1583)